Clinical trialNCT06896474RecruitingInterventional

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

SponsorBeth Israel Deaconess Medical CenterEnrollment402Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to learn the intervention's effectiveness. Decision aids will be mailed and sent via patient portal and/or via email (when portal/email addresses are available) to patients before their first surgical encounter. The central hypothesis is that the novel intervention will be a key resource to support shared decision making leading to higher quality treatment decisions and as result improved care and outcomes.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Mara Schonberg, MD
Beth Israel Deaconess Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Beckman Research Institute of the City of Hope
Los Angeles, California, United States
Jennifer Tseng, MD
Not, yet, recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Mara Schonberg, MD
Recruiting
Brigham and Women'S Hospital
Boston, Massachusetts, United States
Ko Un Park, MD
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Rachel Freedman, MD
Not, yet, recruiting
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Corrine Zarwan, MD
Not, yet, recruiting
Beth Israel Deaconess Hospital
Needham, Massachusetts, United States
Ranjna Sharma
Not, yet, recruiting
Dana-Farber/brigham and Women'S Cancer Center at South Shore Hospital
Weymouth, Massachusetts, United States
Suniti Nimbkar, MD
Not, yet, recruiting
Rutgers State University of New Jersey Medical School
Newark, New Jersey, United States
Susan Pories, MD
Not, yet, recruiting
University of New Mexico
Albuquerque, New Mexico, United States
Sangeetha Prabhakaran, MD
Not, yet, recruiting
University of Rochester
Rochester, New York, United States
Allison Magnuson, MD
Not, yet, recruiting
Duke University
Durham, North Carolina, United States
Shelley Huang, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Feb 2026
Primary completion: 1 Oct 2032
Completion: 30 Sept 2033
Last update posted: 7 Apr 2026
Registered enrollment: 402
Registry id: NCT06896474

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.